Kiyoshi Kurokawa

Title: Kiyoshi Kurokawa: Innovator in Pharmaceutical Chemistry

Introduction

Kiyoshi Kurokawa is a notable inventor based in Shinjuku-ku, Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address health issues related to vitamin deficiencies.

Latest Patents

Kurokawa holds two patents that showcase his innovative work. The first patent is for an inhibitor of protein modification products formation. This invention aims to provide a solution for inhibiting vitamin B6 deficiency diseases, particularly as a renal protective agent. The active ingredient in this patent includes free or salt-form compounds represented by specific formulae, where R1 is a substituted or unsubstituted aromatic ring, and R2, R3, and R4 can be various organic groups or hydrogen atoms.

The second patent involves a phenylene derivative that contains either a tetrazole ring or a thiazolidinedione ring. This invention presents a compound characterized by a cyclic group and a 1H-tetrazol-5-yl or a 2,4-dioxothiazolidin-5-yl group. The compound can also exist as a pharmacologically acceptable salt or ester.

Career Highlights

Throughout his career, Kurokawa has worked with various companies, including Sankyo Company, Limited. His work has significantly impacted the pharmaceutical industry, particularly in the development of innovative therapeutic agents.

Collaborations

Kurokawa has collaborated with notable colleagues such as Toshio Miyata and Hiroaki Yanagisawa. These collaborations have further enhanced his research and development efforts in the field of pharmaceutical chemistry.

Conclusion

Kiyoshi Kurokawa is a distinguished inventor whose work in pharmaceutical chemistry has led to important advancements in health-related compounds. His patents reflect a commitment to addressing critical health issues through innovative solutions.